S141 CLINICAL OUTCOMES OF LENTIGLOBIN GENE THERAPY FOR TRANSFUSION-DEPENDENT β-THALASSAEMIA (TDT) FOLLOWING COMPLETION OF THE NORTHSTAR (HGB-204) STUDY

Authors :: Yi Bin Chen
Phoebe Joy Ho
Morris Kletzel
Alexandria Petrusich
M.C. Walters
John E.J. Rasko
Usanarat Anurathapan
M. Schmidt
Philippe Leboulch
Gary J. Schiller
Alexis A. Thompson
B. Deary
M. Cavazzana
E. Vichinsky
S. Hongeng
J.L. Kwiatkowski
Source :: HemaSphere. 3:22
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Genetic enhancement
Transfusion dependence
medicine
Hematology
β thalassaemia
business

Full Text Access

Tools